390 related articles for article (PubMed ID: 34131404)
41. TRPV1 antagonists that cause hypothermia, instead of hyperthermia, in rodents: Compounds' pharmacological profiles, in vivo targets, thermoeffectors recruited and implications for drug development.
Garami A; Pakai E; McDonald HA; Reilly RM; Gomtsyan A; Corrigan JJ; Pinter E; Zhu DXD; Lehto SG; Gavva NR; Kym PR; Romanovsky AA
Acta Physiol (Oxf); 2018 Jul; 223(3):e13038. PubMed ID: 29352512
[TBL] [Abstract][Full Text] [Related]
42. Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells.
Thomas KC; Sabnis AS; Johansen ME; Lanza DL; Moos PJ; Yost GS; Reilly CA
J Pharmacol Exp Ther; 2007 Jun; 321(3):830-8. PubMed ID: 17332266
[TBL] [Abstract][Full Text] [Related]
43. Semiconducting Photothermal Nanoagonist for Remote-Controlled Specific Cancer Therapy.
Zhen X; Xie C; Jiang Y; Ai X; Xing B; Pu K
Nano Lett; 2018 Feb; 18(2):1498-1505. PubMed ID: 29342359
[TBL] [Abstract][Full Text] [Related]
44. Expression and functionality of TRPV1 receptor in human MCF-7 and canine CF.41 cells.
Vercelli C; Barbero R; Cuniberti B; Odore R; Re G
Vet Comp Oncol; 2015 Jun; 13(2):133-42. PubMed ID: 23510405
[TBL] [Abstract][Full Text] [Related]
45. TRPV1 antagonists elevate cell surface populations of receptor protein and exacerbate TRPV1-mediated toxicities in human lung epithelial cells.
Johansen ME; Reilly CA; Yost GS
Toxicol Sci; 2006 Jan; 89(1):278-86. PubMed ID: 16120755
[TBL] [Abstract][Full Text] [Related]
46. TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts.
Tsumura M; Sobhan U; Muramatsu T; Sato M; Ichikawa H; Sahara Y; Tazaki M; Shibukawa Y
Cell Calcium; 2012 Aug; 52(2):124-36. PubMed ID: 22656960
[TBL] [Abstract][Full Text] [Related]
47. Unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain.
Akhilesh ; Uniyal A; Gadepalli A; Tiwari V; Allani M; Chouhan D; Ummadisetty O; Verma N; Tiwari V
Life Sci; 2022 Jan; 288():120187. PubMed ID: 34856209
[TBL] [Abstract][Full Text] [Related]
48. Dissecting TRPV1: lessons to be learned?
Grimm C; Aneiros E; de Groot M
Channels (Austin); 2011; 5(3):201-4. PubMed ID: 21654202
[TBL] [Abstract][Full Text] [Related]
49. Transient receptor potential vanilloid 1 antagonism in neuroinflammation, neuroprotection and epigenetic regulation: potential therapeutic implications for severe psychiatric disorders treatment.
Escelsior A; Sterlini B; Belvederi Murri M; Valente P; Amerio A; di Brozolo MR; da Silva BP; Amore M
Psychiatr Genet; 2020 Apr; 30(2):39-48. PubMed ID: 32097233
[TBL] [Abstract][Full Text] [Related]
50. Clinical testing of three novel transient receptor potential cation channel subfamily V member 1 antagonists in a pharmacodynamic intradermal capsaicin model.
Sjögren E; Kullenberg T; Jonzon B; Segerdahl M; Stålberg O; Halldin MM; Sundgren-Andersson AK
Eur J Pain; 2018 Aug; 22(7):1214-1228. PubMed ID: 29504187
[TBL] [Abstract][Full Text] [Related]
51. Research progress and challenges of TRPV1 channel modulators as a prospective therapy for diabetic neuropathic pain.
Liu C; Miao R; Raza F; Qian H; Tian X
Eur J Med Chem; 2023 Jan; 245(Pt 1):114893. PubMed ID: 36395649
[TBL] [Abstract][Full Text] [Related]
52. Brain TRPV1: a depressing TR(i)P down memory lane?
Di Marzo V; Gobbi G; Szallasi A
Trends Pharmacol Sci; 2008 Dec; 29(12):594-600. PubMed ID: 18947889
[TBL] [Abstract][Full Text] [Related]
53. Neuroprotection induced by N-acetylcysteine against cytosolic glutathione depletion-induced Ca2+ influx in dorsal root ganglion neurons of mice: role of TRPV1 channels.
Nazıroğlu M; Ciğ B; Ozgül C
Neuroscience; 2013 Jul; 242():151-60. PubMed ID: 23545271
[TBL] [Abstract][Full Text] [Related]
54. Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?
Szallasi A
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jul; 373(4):273-86. PubMed ID: 16773387
[TBL] [Abstract][Full Text] [Related]
55. Pharmacology of modality-specific transient receptor potential vanilloid-1 antagonists that do not alter body temperature.
Reilly RM; McDonald HA; Puttfarcken PS; Joshi SK; Lewis L; Pai M; Franklin PH; Segreti JA; Neelands TR; Han P; Chen J; Mantyh PW; Ghilardi JR; Turner TM; Voight EA; Daanen JF; Schmidt RG; Gomtsyan A; Kort ME; Faltynek CR; Kym PR
J Pharmacol Exp Ther; 2012 Aug; 342(2):416-28. PubMed ID: 22570364
[TBL] [Abstract][Full Text] [Related]
56. Upregulated Expression of Transient Receptor Potential Cation Channel Subfamily V Receptors in Mucosae of Patients with Oral Squamous Cell Carcinoma and Patients with a History of Alcohol Consumption or Smoking.
Sakakibara A; Sakakibara S; Kusumoto J; Takeda D; Hasegawa T; Akashi M; Minamikawa T; Hashikawa K; Terashi H; Komori T
PLoS One; 2017; 12(1):e0169723. PubMed ID: 28081185
[TBL] [Abstract][Full Text] [Related]
57. Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites.
Hodgetts KJ; Blum CA; Caldwell T; Bakthavatchalam R; Zheng X; Capitosti S; Krause JE; Cortright D; Crandall M; Murphy BA; Boyce S; Brian Jones A; Chenard BL
Bioorg Med Chem Lett; 2010 Aug; 20(15):4359-63. PubMed ID: 20615696
[TBL] [Abstract][Full Text] [Related]
58. In vitro characterization of the thermoneutral transient receptor potential vanilloid-1 (TRPV1) inhibitor GRTE16523.
Damann N; Bahrenberg G; Stockhausen H; Habermann CJ; Lesch B; Frank-Foltyn R; Lee J; Ann J; Christoph T
Eur J Pharmacol; 2020 Mar; 871():172934. PubMed ID: 31954706
[TBL] [Abstract][Full Text] [Related]
59. Capsaicin: TRPV1-independent mechanisms and novel therapeutic possibilities.
Braga Ferreira LG; Faria JV; Dos Santos JPS; Faria RX
Eur J Pharmacol; 2020 Nov; 887():173356. PubMed ID: 32763303
[TBL] [Abstract][Full Text] [Related]
60. TRPV1 antagonism by piperazinyl-aryl compounds: A Topomer-CoMFA study and its use in virtual screening for identification of novel antagonists.
Kristam R; Rao SN; D'Cruz AS; Mahadevan V; Viswanadhan VN
J Mol Graph Model; 2017 Mar; 72():112-128. PubMed ID: 28092830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
